Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome

Critical Care Medicine

Volumn 24, Issue 7, 1996, Pages 1107-1116

  Godin, Paul J ^a   Buchman, Timothy G ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endotoxin; inflammatory response; multiple organ dysfunction; pathogenicity; septic shock; systemic inflammatory response syndrome

Indexed keywords

CENTOXIN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; ENDOTOXEMIA; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK;

ANIMALS; HEART; HUMANS; INFLAMMATION; MODELS, THEORETICAL; MULTIPLE ORGAN FAILURE; RESPIRATORY SYSTEM;

EID: 0029893535     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199607000-00008     Document Type: Review

References (79)

1. Tilney NL, Bailey GI, Morgan AP: Sequential system failure after rupture of abdominal aortic aneurysms: An unsolved problem in postoperative care. Ann Surg 1973; 178:117-122
2. Fry DE, Garrison RN, Heitch RC: Determinants of death in patients with intraabdominal abscess. Surgery 1980; 89:517-523
3. Fry DE, Garrison RN, Williams HC: Patterns of morbidity and mortality in splenectomy for trauma. Am Surg 1980; 46:28-32
4. Baue AE: Multiple, progressive or sequential systems failure. Arch Surg 1975; 110:779-781
5. Border JR, Chemier R, McManamy RH, et al: Multiple systems organ failure: Muscle fuel deficit with visceral protein malnutrition. Surg Clin North Am 1976; 56:1147-1167
6. Eiseman B, Beart R, Norton L: Multiple organ failure. Surg Gynecol Obstet 1977; 144:323-326
7. Fry DE, Pearlstein L, Fulton RL, et al: Multiple system organ failure. Arch Surg 1980; 115:136-140
8. Danner RL, Elin RJ, Hosseini JM, et al: Endotoxemia in human septic shock. Chest 1991; 99:169-175
9. Norton LW: Does drainage of intraabdominal pus reverse multiple organ failure? Am J Surg 1985; 149:347-350
10. Goris RJA, teBoekhorst TPA, Nuytinck KS, et al: Multiple organ failure: Generalized autodestructive inflammation? Arch Surg 1985; 120:1109-1115
11. Marshall JC, Christou NV, Hom R, et al: The microbiology of multiple organ failure. Arch Surg 1988; 123:309-315
12. Cerra FB, Maddaus MA, Dunn DL, et al: Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992; 127:163-169
13. Beutler B, Greenwald D, Hulmes K, et al: Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature 1985; 316:552-554
14. Hesse DG, Tracey KJ, Fong Y, et al: Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166:147-153
15. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-871
16. Tracey KJ, Fong Y, Hesse D, et al: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664
17. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-473
18. Okusawa S, Gelfand JA, Ikejima T, et al: Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81:1162-1172
19. Wakabayshi G, Gelfand JA, Burke JF, et al: A specific receptor antagonist for interleukin 1 prevents E. coli induced shock in rabbits. FASEB J 1991; 5: 338-343
20. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978
21. Baue AE: The horror autotoxicus and multiple-organ failure. Arch Surg 1992; 127:1451-1462
22. Baumgartner JD, Heumann D, Gerain J, et al: Association between protective efficacy of anti LPS antibodies and suppression of LPS induced TNF-α and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies. J Exp Med 1990; 171: 889-896
23. Hinshaw LB, Tekamp-Olson P, Chang AC, et al: Survival of primates in LD100 septic shock following therapy with antibody to TNF-α. Circ Shock 1990; 30: 279-292
24. Fischer E, Marano MA, VanZee KJ, et al: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992; 89:1551-1557
25. VanZee KJ, Kohno T, Fischer E, et al: Tumor necrosis factor (TNF) soluble receptors protect against excessive TNFα in infection, injury. Abstr. FASEB J 1992; 6:A1715
26. Ziegler EJ, McCutchman JA, Fierer J, et al: Treatment of Gram-negative bacteremia and shock with human anti-serum to a mutant E. coli. N Engl J Med 1982; 307:1225-1230
27. Ziegler EJ, Fisher CJ, Sprung CL, et al: Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-436
28. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 1-5
29. Quezado AM, Natanson C, Ailing DW, et al: A controlled trial of HA-1A in a canine model of Gram-negative septic shock. JAMA 1993; 269:2221-2227
30. Fischer CJ, Opal SM, Dhainaut J, et al: Influence on an anti-tumor necrosis factor monoclonal antibody on cytokine levels of patients with sepsis. Crit Care Med 1993; 21:318-327
31. Dhainaut J-F, Vincent J-L, Richard C, et al: CDP571, a humanized antibody to human tumor necrosis factor-α: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Crit Care Med 1995; 23:1461-1469
32. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995; 273:934-941
33. Fisher CJ, Dhainaut J-F, Opal SM, et al: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo controlled trial. JAMA 1994; 271:1836-1843
34. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in sepsis syndrome. Ann Intern Med 1993; 119:771-778
35. Agosti JM, Fisher CJ, Opal SM, et al and sTNFR Sepsis Study Group: Treatment of patients with sepsis syndrome with soluble receptor (sTNFR). In: Proceedings of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4-7, 1994, p 65
36. Suffredini AF, Reda D, Banks S, et al: Effects of soluble tumor necrosis factor receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 1995; 155: 5038-5045
37. VanderPoll T, Levi M, vanDeventer SJ, et al: Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994; 83:446-451
38. Goldie AS, Fearon KCH, Ross JA, et al: Natural cytokine antagonists and endogenous antiendotoxin core Ab in sepsis syndrome. JAMA 1995; 274:172-177
39. Deitch EA: Tumor necrosis factor as the proximal mediator of sepsis - Or this too will pass. Crit Care Med 1995; 23: 1457-1458
40. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
41. Holland JH: Hidden Order: How Adaptation Builds Complexity. New York, Addison Wesley, 1995, pp 1-32
42. May RM: Simple mathematical models with very complicated dynamics. Nature 1976; 261:459-167
43. Baxt WG: Complexity, chaos and human physiology: The justification for non-linear neural computation analysis. Cancer Lett 1994; 77:85-95
44. West B: Fractal Physiology and Chaos in Medicine. New Jersey, World Scientific, 1990
45. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of illness classification system. Crit Care Med 1985; 13:818-829
46. Buchman TG, Kubos KL, Seidler AJ, et al: A comparison of statistical and connectionist models for the prediction of chronicity in a surgical intensive care unit. Crit Care Med 1994; 22:750-764
47. Doig GS, Inman KJ, Sibbald EJ, et al: Modelling mortality in the ICU: Comparing the performance of a neural network with multivariate logistic regression. Proceedings of the Annual Symposium on Computer Applications in Medical Care 1993, pp 361-365
48. Chalfin DB, Flaster E, Fein AM: The use of neural networks (NN's) to predict outcome for critically ill patients with Gram-negative sepsis (GNS). Abstr. Crit Care Med 1995; 23(Suppl 1):A51
49. Cannon WB: The Wisdom of the Body. New York, WW Norton, 1927
50. Goldberger AL, West BJ: Chaos in physiology: Health or disease?In: Chaos in Biological Systems. Holton A, Olsen LF (Eds). New York, Plenum Press, 1987
51. Goldberger AL, West BJ, Bhargava V: Nonlinear mechanisms in physiology and pathophysiology. In: Proceedings of the 11th IMACS World Congress at Oslo, Norway. Wahlstrom B, Henrikson R, Sunby NP (Eds). Amsterdam, North-Holland, 1985
52. Goldberger AL: Applications of chaos to physiology and medicine. In: Applied Chaos. Kim JH, Stringer J (Eds). New York, John Wiley & Sons, 1992
53. Elbert T, Ray WJ, Kowalik ZJ, et al: Chaos and Physiology: Deterministic chaos in excitable cell assemblies. Physiol Rev 1994; 74:1-47
54. Glass L, Mackey MC: From Clocks to Chaos: The Rhythms of Life. Princeton, NJ, Princeton University Press, 1988
55. Braiman Y, Lindner JF, Ditto WL: Taming spatiotemporal chaos with disorder. Nature 1995; 378:465-467
56. Goldbeter A: Models for oscillations and excitability in biochemical systems. In: Mathematical Models in Molecular and Cellular Biology. Segel LA (Ed). Cambridge, MA, Cambridge University Press, 1980
57. Kauffman SA: The Origins of Order: Self-Organization and Selection in Evolution. New York, Oxford University Press, 1993
58. Weisbuch G, Stauffer D: Phase transition in cellular random Boolean nets. Journal de Physique 1987; 48:11-22
59. Langton CG: Adaptation to the edge of chaos. In: Artificial Life II: A Proceedings Volume in the Santa Fe Institute Studies in the Sciences of Complexity. Vol 10. Langton CG, Farmer JD, Rasmussen S, et al (Eds). Reading, MA, Addison Wesley, 1992
60. Woo M, Stevenson W, Moser D, et al: Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J 1992; 123:704-710
61. Fleisher L, Pincus S, Rosenbaum S: Approximate entropy of heart rate as a correlate of postoperative ventricular dysfunction. Anesthesiology 1993; 78: 683-692
62. Singer D, Martin G, Magid N, et al: Low heart rate variability and sudden cardiac death. J Electrocardiol 1988; 21:S46-S55
63. Pincus SM: Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA 1991; 88:2297-2301
64. Pincus SM, Gladstone IM, Ehrenkranz RA: A regularity statistic for medical data analysis. J Clin Monit 1991; 7:335-345
65. Pincus SM: Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol 1992; 262: E741-E754
66. Pincus SM: Greater signal regularity may indicate increased system isolation. Math Biosci 1994; 122:161-181
67. Pincus SM, Goldberger AL: Physiological time-series analysis: What does regularity quantify? Am J Physiol 1994; 266: H1643-H1656
68. Sands KE, Appel ML, Lilly LS, et al: Power spectrum analysis of heart rate variability in human cardiac transplant recipients. Circulation 1989; 79:76-82
69. Lemeshow S, LeGall JR: Modeling the severity of illness of ICU patients. A systems update. JAMA 1994; 272: 1049-1055
70. Kaplan DT, Furman MI, Pincus SM, et al: Aging and the complexity of cardiovascular dynamics. Biophys J 1991; 59: 945-949
71. Goldstein B, Kepmpski MH, Stair D, et al: Autonomic modulation of heart rate variability during endotoxin shock in rabbits. Crit Care Med 1995; 23: 1694-1702
72. Garrard CS, Kontoyannis DA, Piepoli M: Spectral analysis of heart rate variability in sepsis syndrome. Clin Auton Res 1993; 3:5-13
73. Morgan L, Szaflarski N, Seiver A: Fourth order blood pressure waves seen using an interactive computer system. Abstr. Crit Care Med 1993; 21:3212
74. Kim R, Hsu J, Kacin M, et al: Low-frequency, periodic fluctuations in physiologic variables of critically ill patients. Abstr. Crit Care Med 1995; 23:A26
75. Winchell RJ, Hoyt DB: Spectral analysis of heart rate variability in the ICU. J Surg Res 1996; 63:11-16
76. Saul JP, Kaplan DT, Kitney RI: Nonlinear interactions between respiration and heart rate: Classical physiology or entrained nonlinear oscillators. In: Proceedings. Computers in Cardiology 1988. Washington, DC, IEEE Computer Society Press, 1989, pp 299-302
77. Engoren M: Approximate entropy (ApEn) as a measure of respiratory failure during weaning. Crit Care Med 1995; 23(Suppl 1):A52
78. Kauffman SA, Johnsen S: Coevolution to the edge of chaos: Coupled fitness landscapes, poised states and coevolutionary avalanches. J Theor Biol 1991; 149:467-505
79. Godin PJ, Fleisher LA, Eidsath A, et al: Experimental human endotoxemia increases cardiac regularity: Results from a prospective, randomized, crossover trial. Crit Care Med 1996; 24:1117-1124